Form 8.3 - AXA INVESTMENT MANAGERS: Alpha Group International plc
GlobeNewswire
2025-07-01

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
Rule 8.3 of the Takeover Code (the "Code")

1.        KEY INFORMATION

(a)   Full name of discloser:AXA Investment Managers S.A.
(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):
        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.
 
(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:
        Use a separate form for each offeror/offeree
Alpha Group International plc
(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: 
(e)   Date position held/dealing undertaken:
        For an opening position disclosure, state the latest practicable date prior to the disclosure
30 June 2025
(f)   In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?
        If it is a cash offer or possible cash offer, state "N/A"
N/A

2.        POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a)      Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)


Class of relevant security:

0.2p ordinary
 InterestsShort positions
 Number%Number%
(1)   Relevant securities owned and/or controlled:707,1041.67  
(2)   Cash-settled derivatives:

    
(3)   Stock-settled derivatives (including options) and agreements to purchase/sell:    
TOTAL:707,1041.67  

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b)      Rights to subscribe for new securities (including directors' and other employee options)

Class of relevant security in relation to which subscription right exists: 
Details, including nature of the rights concerned and relevant percentages: 

3.        DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a)        Purchases and sales

Class of relevant securityPurchase/Sale

Number of securitiesPrice per unit
0.2p ordinarySale4,147GBP 31.85

(b)        Cash-settled derivative transactions

Class of relevant securityProduct description
e.g. CFD
Nature of dealing
e.g. opening/closing a long/short position, increasing/reducing a long/short position
Number of reference securitiesPrice per unit
     

(c)        Stock-settled derivative transactions (including options)

(i)        Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitType
e.g. American, European etc.
Expiry dateOption money paid/ received per unit
        

(ii)        Exercise

Class of relevant securityProduct description
e.g. call option
Exercising/ exercised againstNumber of securitiesExercise price per unit
     

(d)        Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealing
e.g. subscription, conversion
DetailsPrice per unit (if applicable)
    

4.        OTHER INFORMATION

(a)        Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:
Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"
None



(b)        Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:
(i)   the voting rights of any relevant securities under any option; or
(ii)   the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:
If there are no such agreements, arrangements or understandings, state "none"
None



(c)        Attachments

Is a Supplemental Form 8 (Open Positions) attached?NO


Date of disclosure:01 July 2025
Contact name:Sabrina AID
Telephone number*:+33 1 44 45 58 79

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.





More from GlobeNewswire
UK Property: An Exceptional Entry Point for Private Capital — Oakmere Property Partners Harnesses Market Dynamics for High-Calibre Investors GlobeNewswire
Bolivia, Costa Rica, Ecuador, and Panama Advance their Women, Peace and Security National Action Plans GlobeNewswire
Paroxysmal Nocturnal Hemoglobinuria Market Set for Robust Growth During the Forecast Period (2025–2034) Owing to the Advancements in Complement Inhibitor Therapies | DelveInsight GlobeNewswire
ROSEN, A LEADING NATIONAL FIRM, Encourages Red Cat Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – RCAT GlobeNewswire
Global Clinical Trial Support Services Market is Predicted to Cross USD 43 Billion by 2032 | DelveInsight GlobeNewswire
WinnerMining: Are cryptocurrency fluctuations making people panic? No, it's the business opportunities of cloud mining. GlobeNewswire
Alugue Pousadas is now 123Reserve.com: Discover the New Hotel and Inn Booking Platform GlobeNewswire
New Memoir FIRE ON THE MOUNTAIN Chronicles Parallel Transformation of Patient and Therapist GlobeNewswire
Equasens: General meeting - Results of the votes GlobeNewswire
Danone completes the acquisition of Kate Farms, enhancing its U.S. specialized nutrition offerings GlobeNewswire

About Us

Partners

Copyright (C) 2025 BizWire Express All Rights Reserved.